These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 25558811)
1. The RIVUR trial: a factual interpretation of our data. Mattoo TK; Carpenter MA; Moxey-Mims M; Chesney RW; Pediatr Nephrol; 2015 May; 30(5):707-12. PubMed ID: 25558811 [TBL] [Abstract][Full Text] [Related]
2. Renal Scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial. Mattoo TK; Chesney RW; Greenfield SP; Hoberman A; Keren R; Mathews R; Gravens-Mueller L; Ivanova A; Carpenter MA; Moxey-Mims M; Majd M; Ziessman HA; Clin J Am Soc Nephrol; 2016 Jan; 11(1):54-61. PubMed ID: 26555605 [TBL] [Abstract][Full Text] [Related]
3. The RIVUR study: a review of its findings. Cara-Fuentes G; Gupta N; Garin EH Pediatr Nephrol; 2015 May; 30(5):703-6. PubMed ID: 25503325 [TBL] [Abstract][Full Text] [Related]
4. The role of antimicrobial prophylaxis in the management of children with vesicoureteral reflux--the RIVUR study outcomes. Mathews R; Mattoo TK Adv Chronic Kidney Dis; 2015 Jul; 22(4):325-30. PubMed ID: 26088078 [TBL] [Abstract][Full Text] [Related]
5. Risk Factors for Recurrent Urinary Tract Infection and Renal Scarring. Keren R; Shaikh N; Pohl H; Gravens-Mueller L; Ivanova A; Zaoutis L; Patel M; deBerardinis R; Parker A; Bhatnagar S; Haralam MA; Pope M; Kearney D; Sprague B; Barrera R; Viteri B; Egigueron M; Shah N; Hoberman A Pediatrics; 2015 Jul; 136(1):e13-21. PubMed ID: 26055855 [TBL] [Abstract][Full Text] [Related]
6. The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux. Carpenter MA; Hoberman A; Mattoo TK; Mathews R; Keren R; Chesney RW; Moxey-Mims M; Greenfield SP; Pediatrics; 2013 Jul; 132(1):e34-45. PubMed ID: 23753091 [TBL] [Abstract][Full Text] [Related]
7. Antimicrobial prophylaxis for children with vesicoureteral reflux. ; Hoberman A; Greenfield SP; Mattoo TK; Keren R; Mathews R; Pohl HG; Kropp BP; Skoog SJ; Nelson CP; Moxey-Mims M; Chesney RW; Carpenter MA N Engl J Med; 2014 Jun; 370(25):2367-76. PubMed ID: 24795142 [TBL] [Abstract][Full Text] [Related]
8. Why Does Prevention of Recurrent Urinary Tract Infection not Result in Less Renal Scarring? A Deeper Dive into the RIVUR Trial. Wang HH; Kurtz M; Logvinenko T; Nelson C J Urol; 2019 Aug; 202(2):400-405. PubMed ID: 31026216 [TBL] [Abstract][Full Text] [Related]
9. The Swedish infant high-grade reflux trial: UTI and renal damage. Nordenström J; Sjöström S; Sillén U; Sixt R; Brandström P J Pediatr Urol; 2017 Apr; 13(2):146-154. PubMed ID: 28215835 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial prophylaxis for vesicoureteral reflux: which subgroups of children benefit the most? Zhao B; Ivanova A; Shaikh N Pediatr Nephrol; 2024 Jun; 39(6):1859-1863. PubMed ID: 38244067 [TBL] [Abstract][Full Text] [Related]
11. Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study. Keren R; Carpenter MA; Hoberman A; Shaikh N; Matoo TK; Chesney RW; Matthews R; Gerson AC; Greenfield SP; Fivush B; McLurie GA; Rushton HG; Canning D; Nelson CP; Greenbaum L; Bukowski T; Primack W; Sutherland R; Hosking J; Stewart D; Elder J; Moxey-Mims M; Nyberg L Pediatrics; 2008 Dec; 122 Suppl 5(Suppl 5):S240-50. PubMed ID: 19018048 [TBL] [Abstract][Full Text] [Related]
12. Recurrent Urinary Tract Infections in Children With Bladder and Bowel Dysfunction. Shaikh N; Hoberman A; Keren R; Gotman N; Docimo SG; Mathews R; Bhatnagar S; Ivanova A; Mattoo TK; Moxey-Mims M; Carpenter MA; Pohl HG; Greenfield S Pediatrics; 2016 Jan; 137(1):. PubMed ID: 26647376 [TBL] [Abstract][Full Text] [Related]
14. The RiVUR Study Outcomes and Implications on the Management of Vesicoureteral Reflux. Damm T; Mathews R Arch Nephrol Ren Stud; 2022; 2(1):1-5. PubMed ID: 35928985 [TBL] [Abstract][Full Text] [Related]
15. Controversies in the management of vesicoureteral reflux: the rationale for the RIVUR study. Mathews R; Carpenter M; Chesney R; Hoberman A; Keren R; Mattoo T; Moxey-Mims M; Nyberg L; Greenfield S J Pediatr Urol; 2009 Oct; 5(5):336-41. PubMed ID: 19570724 [TBL] [Abstract][Full Text] [Related]
16. Are prophylactic antibiotics indicated after a urinary tract infection? Mattoo TK Curr Opin Pediatr; 2009 Apr; 21(2):203-6. PubMed ID: 19663037 [TBL] [Abstract][Full Text] [Related]
17. Antibiotic prophylaxis in the management of vesicoureteric reflux: a randomized double-blind placebo-controlled trial. Hari P; Hari S; Sinha A; Kumar R; Kapil A; Pandey RM; Bagga A Pediatr Nephrol; 2015 Mar; 30(3):479-86. PubMed ID: 25173357 [TBL] [Abstract][Full Text] [Related]
18. Long-term, low-dose prophylaxis against urinary tract infections in young children. Brandström P; Hansson S Pediatr Nephrol; 2015 Mar; 30(3):425-32. PubMed ID: 24906665 [TBL] [Abstract][Full Text] [Related]
19. The Swedish infant high-grade reflux trial: Study presentation and vesicoureteral reflux outcome. Nordenström J; Holmdahl G; Brandström P; Sixt R; Stokland E; Sillén U; Sjöström S J Pediatr Urol; 2017 Apr; 13(2):130-138. PubMed ID: 27889221 [TBL] [Abstract][Full Text] [Related]
20. Vesicoureteral reflux and continuous prophylactic antibiotics. Lee T; Park JM Investig Clin Urol; 2017 Jun; 58(Suppl 1):S32-S37. PubMed ID: 28612058 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]